Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter To Editor
2005:71:5;360-361
doi: 10.4103/0378-6323.16792
PMID: 16394466

An evaluation of the efficacy and safety of tazarotene (0.1%) cream in acne vulgaris

PK Nigam, S Anant
 Department of Dermatology-Venereology, Pt. J. N. M. Medical College and Assoc. B.R.A.M. Hospital, Raipur-492 001, India

Correspondence Address:
P K Nigam
Department of Dermatology-Venereology, D-30-A, Shailendra Nagar, Raipur-492 001
India
How to cite this article:
Nigam P K, Anant S. An evaluation of the efficacy and safety of tazarotene (0.1%) cream in acne vulgaris. Indian J Dermatol Venereol Leprol 2005;71:360-361
Copyright: (C)2005 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Systemic retinoids have long been used in the treatment of acne. Topical retinoids were developed to avoid many of their side effects. Tazarotene is a receptor selective retinoid[1] with low systemic absorption, rapid elimination and plasma concentration about 100 times lower than those observed after oral therapy with isotretinoin. It normalizes keratinocyte differentiation, reverses keratinocyte hyper-proliferation, and has anti-inflammatory effects.[2] We evaluated the efficacy and safety of 0.1% tazarotene cream in acne vulgaris.

The study was conducted in 46 consecutive patients with mild to moderate acne, as classified by Bershad et al,[3] i.e. 10-200 non-inflammatory lesions (open and closed comedones), 10-60 inflammatory lesions (papules and pustules), and fewer than 3 nodulocystic lesions, after due consent. Patients with severe nodulocystic acne were not included in the study. None of the patients was on systemic retinoids prior to the study. A washout period of two weeks was required for topical acne medications. Female patients were excluded if they were pregnant, breastfeeding or sexually active and not using contraception. Patients with known hepatic or renal disease were also excluded from the study.

Tazarotene 0.1% cream (a uniform brand) was applied as a thin film over the affected area once daily in the evening after washing the area with soap and water. The response was evaluated at 2, 4, 8 and 12 weeks. Simultaneously, the patients were also evaluated for any local side effects, including skin erythema, burning, peeling and tenderness at baseline and throughout the study. Data was analyzed using the paired ′t′ test.

There were 20 males and 26 females, their age ranging from 17 years to 29 years (mean age, 22.48 ± 2.7 years). The mean count of different lesions at baseline and at 2, 4, 8 and 12 weeks are shown in [Table - 1]. A statistically significant reduction was seen at 8 and 12 weeks in the mean number of papules (66.3% and 82.3%), pustules (90.1% and 94.5%), nodules (62.2% and 79.7%), open comedones (70.8% and 85.6%), and closed comedones (72.7% and 86.1%) respectively. There was a statistically significant reduction in both the inflammatory and non-inflammatory lesion count at all study periods. The mean inflammatory acne count decreased by 70.6% and 84.5%, and the non-inflammatory acne count decreased by 71.9% and 85.8% at 8 weeks and 12 weeks respectively. The mean total lesion count reduced from 51.9 at baseline to 14.9 (28.8%) and 7.8 (14.9%) at 8 weeks and 12 weeks, which was also a significant reduction.

Adverse effects were noticed in 5 (10.8%) patients, in the form of mild burning in 3 (6.5%), itching in 3 (6.5%), erythema in 2 (4.3%) and desquamation in one (2.2%) patient. Three of these patients initially intolerant of the treatment decided to continue the treatment on reducing the application time to 15 minutes/day in the evening. Two patients discontinued the treatment and asked to be shifted to another drug. In one study with overnight topical tazarotene therapy, 9% of patients withdrew due to local irritation.[4] In another study, untoward effects were experienced by 11.9% of patients during the treatment.[5]

Topical tazarotene has been observed to show beneficial effects in acne vulgaris.[5]-[6] The efficacy and tolerability of tazarotene has been found equal to or superior to tretinoin 0.1% gel[3] and adapalene 0.1% gel.[6] Except for ovulating females, where due safety measures should be taken, topical tazarotene appears to be a safe and effective topical remedy for acne vulgaris.

References
1.
Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhorta M, et al. Tazarotene induced gene 2 (TIG 2), a novel retinoid responsive gene in skin. J Invest Dermatol 1997;109:91-5.
[Google Scholar]
2.
Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol 2000;43:S31-5.
[Google Scholar]
3.
Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW, Persaud AN, et al. Successful treatment of acne vulgaris using a new method: Results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol 2002;138:481-9.
[Google Scholar]
4.
Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM, et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. Cutis 1999;63:349-54.
[Google Scholar]
5.
Saple DG, Torsekar RG, Pawanarkar V, Dhanalakshmi UR, Ravichandran G, Kaur D, et al. An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris. Indian J Dermatol Venereol Leprol 2004;70:92-5.
[Google Scholar]
6.
Webster GF, Guenther L, Poulin YP, Solomon BA, Lowen K, Lee J, et al. A multicenter double blind, randomized comparision study of the efficacy and tolerability of once daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne. Cutis 2002;69:4-11.
[Google Scholar]

Fulltext Views
1,412

PDF downloads
278
Show Sections